ZA961973B - Sertoli cells as transplantation facilitator for cell transplantation - Google Patents

Sertoli cells as transplantation facilitator for cell transplantation

Info

Publication number
ZA961973B
ZA961973B ZA961973A ZA961973A ZA961973B ZA 961973 B ZA961973 B ZA 961973B ZA 961973 A ZA961973 A ZA 961973A ZA 961973 A ZA961973 A ZA 961973A ZA 961973 B ZA961973 B ZA 961973B
Authority
ZA
South Africa
Prior art keywords
transplantation
facilitator
sertoli cells
cell
cell transplantation
Prior art date
Application number
ZA961973A
Other languages
English (en)
Inventor
Paul R Sanberg
Don F Cameron
Cesario V Borlongan
Original Assignee
Univ South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Florida filed Critical Univ South Florida
Publication of ZA961973B publication Critical patent/ZA961973B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0683—Cells of the male genital tract, e.g. prostate, epididymis; Non-germinal cells from testis, e.g. Leydig cells, Sertoli cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/24—Genital tract cells, non-germinal cells from gonads
    • C12N2502/246—Cells of the male genital tract, non-germinal testis cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Prostheses (AREA)
ZA961973A 1995-03-13 1996-03-12 Sertoli cells as transplantation facilitator for cell transplantation ZA961973B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/402,387 US5830460A (en) 1995-03-13 1995-03-13 Sertoli cells as transplantation facilitator for cell transplantation

Publications (1)

Publication Number Publication Date
ZA961973B true ZA961973B (en) 1996-09-17

Family

ID=23591668

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961973A ZA961973B (en) 1995-03-13 1996-03-12 Sertoli cells as transplantation facilitator for cell transplantation

Country Status (10)

Country Link
US (2) US5830460A (de)
JP (1) JPH11509170A (de)
KR (1) KR100297898B1 (de)
AT (1) ATE270893T1 (de)
AU (1) AU709246B2 (de)
CA (1) CA2215303C (de)
DE (1) DE69632905D1 (de)
NZ (1) NZ304647A (de)
TW (1) TW429151B (de)
ZA (1) ZA961973B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355780B1 (en) * 1995-02-22 2002-03-12 Yeda Research And Development Co. Ltd. Antibodies to the death domain motifs of regulatory proteins
US5830460A (en) 1995-03-13 1998-11-03 University Of South Florida Sertoli cells as transplantation facilitator for cell transplantation
US7399751B2 (en) * 1999-11-04 2008-07-15 Sertoli Technologies, Inc. Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
EP1949904A3 (de) 1999-04-27 2008-08-06 Layton Bioscience, Inc. Zelltherapie für chronische Apoplexie
US20030211085A1 (en) * 2000-03-16 2003-11-13 Sanberg Paul R. Cell therapy for chronic stroke
US6790441B1 (en) 2000-06-13 2004-09-14 University Of South Florida Sertoli cells as biochambers
ATE492636T1 (de) 2002-10-22 2011-01-15 Eisai R&D Man Co Ltd Spezifisch in postmitotischen dopamin- produzierenden neuronalen vorläuferzellen exprimiertes gen
CA2531022C (en) * 2003-07-03 2014-09-09 Jannette Dufour Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
WO2006118564A2 (en) * 2004-04-29 2006-11-09 Washington State University Research Foundation MODIFIED CELLS EXPRESSING A PROTEIN THAT MODULATES ACTIVITY OF bHLH PROTEINS, AND USES THEREOF
KR101375603B1 (ko) 2004-07-22 2014-04-01 에자이 알앤드디 매니지먼트 가부시키가이샤 Ｌｒｐ４／Ｃｏｒｉｎ 도파민 생산 뉴런 전구 세포 마커
US20070065422A1 (en) * 2005-09-20 2007-03-22 Cameron Don F Induction of immune tolerance by sertoli cells
WO2007119759A1 (ja) 2006-04-11 2007-10-25 Eisai R & D Management Co., Ltd. ドーパミン産生ニューロン前駆細胞マーカー１８７ａ５
JP2010500871A (ja) * 2006-07-28 2010-01-14 セルトセル・バイオテクノロジー・（ユーエス）・コーポレイション 成熟セルトリ細胞およびその使用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829000A (en) 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
DE69133205T2 (de) 1990-10-19 2003-12-11 New York University, New York Eine methode zur transplantation von zellen in das gehirn und ihre therapeutische verwendung
ATE156344T1 (de) 1991-04-25 1997-08-15 Univ Brown Res Found Implantierbare, biokompatible immunisolator- trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte
US5858354A (en) 1991-12-06 1999-01-12 The Trustees Of The University Of Pennsylvania Repopulation of testicular Seminiferous tubules with foreign cells, corresponding resultant germ cells, and corresponding resultant animals and progeny
US5958404A (en) 1994-04-13 1999-09-28 Research Corporation Technologies, Inc. Treatment methods for disease using co-localized cells and Sertoli cells obtained from a cell line
DK0755258T3 (da) 1994-04-13 2002-05-13 Res Corp Technologies Inc Fremgangsmåde til behandling af sygdom ved at anvende Sertoli-celler og allo-transplantater eller xeno-transplantater
US5849285A (en) * 1994-04-13 1998-12-15 Research Corporation Technologies, Inc. Autoimmune disease treatment with sertoli cells and in vitro co-culture of mammal cells with sertoli cells
US5702700A (en) 1995-03-13 1997-12-30 University Of South Florida Sertoli cells as neurorecovery inducing cells for Parkinson's disease
WO1996028174A1 (en) 1995-03-13 1996-09-19 University Of South Florida Sertoli cells as transplantation facilitator for cell transplantation
US5830460A (en) 1995-03-13 1998-11-03 University Of South Florida Sertoli cells as transplantation facilitator for cell transplantation
AU5390696A (en) 1995-04-20 1996-11-07 University Of South Florida Purified and isolated sertoli cell aggregate
US6037175A (en) 1996-03-12 2000-03-14 The University Of South Florida Method and media for enhancing cryopreservation of cells
US6036951A (en) 1996-03-12 2000-03-14 University Of South Florida Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders
US20020065212A1 (en) 1996-11-08 2002-05-30 Selawry Helena P. Methods of treating disease using sertoli cells and allografts or xenografts
US6001643A (en) 1997-08-04 1999-12-14 C-Med Inc. Controlled hydrodynamic cell culture environment for three dimensional tissue growth
US7160724B2 (en) 2000-03-09 2007-01-09 University Of South Florida Human cord blood as a source of neural tissue for repair of the brain and spinal cord
WO2002063938A2 (en) 2000-12-05 2002-08-22 Layton Bioscience Inc. Production and use of dopaminergic cells to treat dopaminergic deficiencies

Also Published As

Publication number Publication date
TW429151B (en) 2001-04-11
AU5189896A (en) 1996-10-02
ATE270893T1 (de) 2004-07-15
KR19980703029A (ko) 1998-09-05
US6649160B1 (en) 2003-11-18
KR100297898B1 (ko) 2001-10-25
CA2215303C (en) 2002-02-12
AU709246B2 (en) 1999-08-26
MX9707027A (es) 1998-06-28
NZ304647A (en) 1998-07-28
DE69632905D1 (de) 2004-08-19
US5830460A (en) 1998-11-03
CA2215303A1 (en) 1996-09-19
JPH11509170A (ja) 1999-08-17

Similar Documents

Publication Publication Date Title
ZA961973B (en) Sertoli cells as transplantation facilitator for cell transplantation
EP0731163A3 (de) Hautkultur und Verfahren zur Herstellung
ZA961597B (en) Method for preparation and transplantation of planar implants and surgical instrument therefor
AU8476698A (en) Human mesenchymal stem cells from peripheral blood
GR3017310T3 (en) Tissue culture method for transformation of plant cells.
NZ335383A (en) Epothilone C,D,E and F for plant protection and cytostatic effects shown in kidney cells
GR3036778T3 (en) -i(IN VITRO) CORNEA EQUIVALENT MODEL.
CA2039315A1 (en) Human hematopoietic stem cell
PL323737A1 (en) Method of controlling sialination of proteins produced by cultures of mammals tissue cells
PL318288A1 (en) Cell growth control in respect to cells encapsulated in artificial body organs
CA2131385A1 (en) Methods, compositions and devices for maintaining and growing human stem or hematopoietic cells
ES8604644A1 (es) Substrato de cultivo para las celulas, tejidos, organos vegetales y plantas enteras
WO1990015877A3 (en) Methods, compositions and devices for growing cells
EP1358895A4 (de) Gewebeäquivalent für die transplantation und verfahren zu seiner herstellung
ATE219654T1 (de) Verfahren zur vermehrung von haaren
AU7878998A (en) Meiosis regulating compounds
CA2126910A1 (en) Isolation and structure of spongistatins 5, 7, 8, and 9
WO2003089581A3 (en) A method to increase the rate of cell growth
AU3155701A (en) Method and compositions for producing cell transplants
IL130457A0 (en) Methods for producing parthenocarpic or female sterile transgenic plants and methods for enhancing fruit setting and development
NZ517996A (en) Method for production of proteinaceous substances
CA2278588A1 (en) Method for increasing the growth of plant cell cultures
AU1833100A (en) Artificial matrix attachment region for increasing expression of genes introduced in plant cells
CA2126911A1 (en) Isolation and structure of spongistatin 2, spongistatin 3, spongistatin 4 and spongistatin 6
NO974239L (no) Sertoliceller som transplantasjonshjelpemidler for celletransplantasjon